resorcinol (resorcin)

04/01/2022 - "To conclude, in this cohort study, topical 15% resorcinol was shown to be effective for mild-to-moderate hidradenitis suppurativa and to have a positive impact on quality of life with an acceptable safety profile."
04/01/2022 - "Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study."
12/01/2017 - "Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up."
11/01/2022 - "Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa."
04/01/2022 - "Those individuals with mild-to-moderate hidradenitis suppurativa (Hurley I-II) who started treatment with topical resorcinol monotherapy between April 2019 and May 2020 were eligible for follow-up. "

08/26/2010 - "The companion paper (DOI: 10.1021/jm100060b) describes how the resorcinol lead was optimized into a compound that is now in clinical trials for the treatment of cancer."
07/01/1992 - "Neoplasms and Nonneoplastic Lesions in the 2-Year Studies: There were no treatment-related increased incidences of neoplasms or nonneoplastic lesions in rats or mice administered resorcinol for 2 years. "
12/01/2015 - "Conversely, in the bowels of Apc(Min/+) mice without colitis, resorcinol administration or 'knockout' of MPO gene coincided with a slight, but discernible increase in colon tumor incidence. "
12/01/2015 - "During experimentally induced colitis, inhibition of MPO by resorcinol dampened colon tumor development. "
02/01/1961 - "Anti-cancer effects of resorcinol derivatives on ascitic and solid forms of Ehrlich carcinoma in mice."

12/01/2016 - "The aim of this study was to evaluate and compare the efficacy of CO2 fractional laser photothermolysis followed by topical application of B-Resorcinol and Glycyrrhetinic acid vs. only topical B-Resorcinol and Glycyrrhetinic acid application for hand solar lentigines treatment. "
12/01/2016 - "Topical application of B-Resorcinol and Glycyrrhetinic acid is effective to lighten hand solar lentigines after 4 weeks of treatment, with or without a previous fractional laser photothermolysis."
12/01/2016 - "Hand solar lentigines of eleven volunteers were divided into two groups: Group A spots received CO2 fractional laser photothermolysis followed by 4 weeks topical application of B-Resorcinol and Glycyrrhetinic acid, and Group B spots received only 4 weeks topical treatments. "
01/01/2018 - "They develop thiamidol, a new thiazolyl-resorcinol derivative, that is a submicromolar tyrosinase inhibitor and effective for treating solar lentigines. "

01/01/2010 - "Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS. "
11/01/2022 - "Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration. "
01/01/2022 - "Patients treated with resorcinol 15% showed a significant improvement in Hidradenitis Suppurativa Clinical Response, International Hidradenitis Suppurativa Severity Score System, and Pain Visual Analogue Scale score from baseline compared to patients treated with clindamycin 1%. "

09/01/1994 - "[Surgery of type A acute aortic dissection with gelatin-resorcin-formal (GRF) biological glue--study of six cases]."
07/01/1994 - "[Efficacy of GRF (gelatin-resorcin-formalin) glue on surgery for type A aortic dissection]."
09/01/2004 - "The aim of this study was to assess the mid-term results of operation for type A acute aortic dissection with the aid of gelatin resorcin formalin glue. "
07/01/1994 - "Gelatin-dialdehyde glue is able to produce the same effects in the area of the aortic wall as the substantially more toxic gelatin-resorcinol-formaldehyde glue and thus could be recommended for clinical trials for treating acute aortic dissections thus far yielding excellent initial results."
01/01/2018 - "Gelatin-resorcinol-formaldehyde glue should be avoided for commissural resuspension in patients with acute aortic dissection."